Dyax

 

Advancing Novel Biotherapeutics Since 1995®

 

Opportunities for growth stem from our established success and valued collaborations.

SEC Filings

  
Filing Description Date Filed Size Sorted Descending View  
10-K annual report Mar 2, 2012 2.6 MB View HTML View PDF View XLS View XBRL Add to Briefcase
10-Q quarterly report Aug 4, 2009 2.4 MB View HTML View PDF View XLS Add to Briefcase
SC TO-I other May 21, 2012 1.5 MB View HTML View PDF View XLS Add to Briefcase
10-Q/A amended quarterly report Aug 18, 2009 1.6 MB View HTML View PDF View XLS Add to Briefcase
10-Q quarterly report Oct 29, 2012 1.3 MB View HTML View PDF View XLS View XBRL Add to Briefcase
10-Q quarterly report Aug 2, 2012 835.4 KB View HTML View PDF View XLS View XBRL Add to Briefcase
10-Q quarterly report Oct 29, 2008 2.0 MB View HTML View PDF View XLS Add to Briefcase
10-Q quarterly report May 2, 2013 828.2 KB View HTML View PDF View XLS View XBRL Add to Briefcase
10-Q quarterly report Aug 2, 2010 1.3 MB View HTML View PDF View XLS Add to Briefcase
10-K annual report Mar 12, 2010 1.9 MB View HTML View PDF View XLS Add to Briefcase
10-K annual report Mar 13, 2007 1.1 MB View HTML View PDF View XLS Add to Briefcase
10-Q quarterly report Nov 3, 2011 968.0 KB View HTML View PDF View XLS View XBRL Add to Briefcase
10-K annual report Mar 3, 2006 857.1 KB View HTML View PDF View XLS Add to Briefcase
10-K annual report Mar 2, 2011 953.7 KB View HTML View PDF View XLS Add to Briefcase
S-1 registration statement May 19, 2000 3.4 MB View HTML View PDF View XLS Add to Briefcase
10-Q quarterly report May 7, 2009 1.2 MB View HTML View PDF View XLS Add to Briefcase
10-Q quarterly report Aug 4, 2011 623.3 KB View HTML View PDF View XLS View XBRL Add to Briefcase
10-Q quarterly report May 2, 2012 569.8 KB View HTML View PDF View XLS View XBRL Add to Briefcase
10-Q quarterly report Nov 2, 2010 956.6 KB View HTML View PDF View XLS Add to Briefcase
10-Q quarterly report Nov 1, 2007 743.7 KB View HTML View PDF View XLS Add to Briefcase
Showing 1-20 of 580 Page: 1 2 3 4 5 ... 29  Next 20
Add to Briefcase = add PDF file to Briefcase

Print

Print Page

 		E-mail

E-mail Page


May 21, 2013, 4:00 PM ET

Stock quote

Exchange NASDAQ (US Dollars)
Price $2.52
Change (%) 0.00 N/A
See more

IR TOOL KIT

Investor Relations Contacts

Jennifer Robinson
Associate Director, Investor Relations and Corporate Communications
Dyax Corp.
Phone: 617-225-2500


See All

 

You are now leaving Dyax.com.

The web site you are about to visit is . It is neither owned nor controlled by Dyax Corp. Dyax is not responsible for the content, products or services on this site.

Do you wish to continue?